Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Prospective Cohort Study of Minimal Residual Disease(MRD) Testing for Early Recurrence Detection in Endometrial and Cervical Cancer

View source ↗

Summary

This clinical trial update outlines a prospective cohort study evaluating minimal residual disease testing to detect early recurrence in endometrial and cervica…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Asan Medical Center | Conditions: Uterine Neoplasms, Cervical Cancer | Status: NOT_YET_RECRUITING